Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HILO: High vs Low Dose Peanut OIT with/without Probiotic
NCT06297083Phase 2Withdrawn
- Sponsor
- Murdoch Children's Research Institute
- Start
- May 2024
- Primary completion
- May 2027
- Modality
- Recombinant Proteins and Enzymes, Live Biotherapeutic Products, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of peanut allergen extract, Lactobacillus rhamnosus GG in peanut allergy, sponsored by Murdoch Children's Research Institute. Planned start May 2024; status: withdrawn.
02
Drugs
peanut allergen extractLactobacillus rhamnosus GG
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT06297083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06297083.